ClinicalTrials.gg
Not yet recruitingNCT06940726GHOSTTONEUpdated Apr 23, 2025

Exploring the Links Between Hearing, Cognition and Brain Activity in People With Tinnitus

An interventional study of Quality of Life questionnaires and Hearing tests in Tinnitus, sponsored by Institut Pasteur. Not yet recruiting. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-04-23.

Sponsored by Institut Pasteur · Not applicable, Interventional, and Basic science

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
114
Allocation
Non-randomized
Ages
18 Years and older
Sex
All
01

Study summary

The goal of this observational study is to understand the mechanisms underlying tinnitus, and improve the clinical assessment strategies needed to develop targeted therapeutic interventions by comparing endogenous attention capacities in healthy subjects and subjects with tinnitus

02

Conditions studied

  • Tinnitus

Browse trials for

Keywords

  • tinnitus
03

In context

Tinnitus

445 studies on the registry are indexed under Tinnitus; 98 are open to participants now.

This study's planned enrollment of 114 is above the median of 60 across 369 interventional studies indexed under Tinnitus.

Browse Tinnitus studies →

Lead sponsor

Institut Pasteur is the lead sponsor of 99 studies on the registry; 41 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age ≥ 18 years
  • Good written and oral comprehension of the French language
  • Normal or corrected vision

Group of people with tinnitus :

  • Chronic tinnitus > 3 months, uni or bilateral, stable (no period of remission)

Control group :

  • No tinnitus

Exclusion criteria

Exclusion Criteria:

  • Presence of a known neurological disorder
  • Presence of a known degenerative pathology
  • Presence of a known hearing impairment
  • Presence of a motor disability of the upper limbs
  • Severe or profound deafness on one or both sides
  • Person under legal protection (guardianship, curatorship, etc.)
  • Use of hearing aids
05

Study design

Phase
Not applicable
Primary purpose
Basic science
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
114 participants (estimated)

Study arms

  • Sham comparator
    Healthy subjects

    Other: Quality of Life questionnaires · Other: Hearing tests · Behavioral: Auditory prediction task · Behavioral: Attention task

  • Experimental
    Subjets with tinnitus

    Other: Quality of Life questionnaires · Other: Hearing tests · Behavioral: Auditory prediction task · Behavioral: Attention task

Interventions

  • OtherQuality of Life questionnaires

    Subjects will complete a number of self-questionnaires on subjects such as attention span, anxiety levels and sleep quality.

  • OtherHearing tests

    listening to sounds on headphones and repeating words

  • BehavioralAuditory prediction task

    listening to sounds and assessing auditory perception

  • BehavioralAttention task

    assessment of reaction time to visual or auditory cues

06

What researchers measure

Primary outcomes

  1. Contingent negative variation (CNV) in EEG

    Time frame: 2 hours

Secondary outcomes

  1. Response reaction time (in ms)

    Comparison of reaction time (RT) variability following response button presses in behavioural tasks

    Time frame: 2 hours

  2. Answer accuracy (% correct answers)

    Comparison of the variability of the number of correct responses following button presses in behavioural tasks.

    Time frame: 2 hours

  3. Cerebral oscillations (alpha bands) obtained by EEG during behavioural tasks

    Time frame: 2 hours

  4. Skin conductance (μS)

    during behavioral task

    Time frame: 2 hours

  5. Heart rate variability (in ms)

    during behavioral task

    Time frame: 2 hours

  6. Pupillometry (pupillary dilation in mm)

    Time frame: 2 hours

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: Undecided

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Start is estimated for May 2025; primary completion for Nov 2027, 30 months later.

Of 152 interventional studies with no phase under Tinnitus, half reached primary completion within 17 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 38. This study's planned 30 months is above that.

How these figures are worked out, and which studies are left out of them.

Registered
Apr 8, 2025
First posted
Apr 23, 2025
StartEst.
May 2025
Primary completionEst.
Nov 2027
CompletionEst.
Nov 2027
Last update
Apr 23, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Apr 23, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06940726
Lead sponsor
Institut Pasteur
Collaborators
IHU reConnect
Responsible party
Sponsor
First posted
Apr 23, 2025
Start date
May 2025 (estimated)
Primary completion
Nov 2027 (estimated)
Completion
Nov 2027 (estimated)
Last update
Apr 23, 2025

Study contacts

Séverine Samson
Contact
severine.samson@pasteur.fr
+33 (0)1 76 53 51 44

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Mar 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion